4DMedical is trading 6.22% lower at A$4.07, with the decline coinciding with a break below the A$4.118 200-day moving average after repeated failures to clear A$4.30–A$4.40 resistance. - Reports describe short interest above 12%, but no definitive catalyst is established. - No ASX announcement was reported for October 5; another market wrap found no clear company-specific news. - The broader market was positive; available evidence does not suggest broad-market weakness drove the fall.